טוען...
Severe active C3 glomerulonephritis triggered by immune complexes and inactivated after eculizumab therapy
BACKGROUND: Understanding the role of alternative complement pathway dysregulation in membranoproliferative glomerulonephritis (MPGN) has led to a dramatic shift in its classification into two subgroups: immune complex-mediated MPGN and complement-mediated MPGN, consisting of dense deposit disease a...
שמור ב:
| הוצא לאור ב: | Diagn Pathol |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5055692/ https://ncbi.nlm.nih.gov/pubmed/27717365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-016-0547-6 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|